Advocates: US FDA Pivot To Preventing Rare Disease Symptoms Means Industry Must Adapt

 
• By Sarah Karlin-Smith
  
two tiny newborn babies
The FDA is becoming more comfortable enrolling young children with rare diseases in trials. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Rare Diseases

More from US FDA